Investor Presentation - First Six Months of 2021
126
Investor presentation
First six months of 2021
2020 assured sustainability performance on key metrics
Novo NordiskⓇ
2020
2019
2018
Environmental
performance
Resources
Energy consumption for operations (1,000 GJ)
Share of renewable power for production sites
Water consumption for production sites (1,000 m³)
Emissions and waste
CO2 emissions from operations and transportation (1,000 tonnes)
Waste from production sites (1,000 tonnes)
Patients
Patients reached with NN's Diabetes care products (est. in millions)
3,191
2,993
3,099
100%
76%
77%
3,368
3,149
3,101
170
306
278
141
124
142
32.8
30.0
29.2
- Hereof reached via the NN Access to Insulin Commitment (est. in millions)
3.2
2.9
0.3
Children reached through CDIC (cumulative)
28,296
25,695
22,876
Donations and other contributions (DKK million)
158
105
103
Employees
Social
Employees (FTE)
45,323
43,258
43,202
88
performance
Employee turnover
7.9%
11.4%
11.7%
Employee engagement
N/A1
91%
91%
Frequency of occupational accidents (number per million working hours)
1.3
2.2
2.4
Other
Animals purchased for research
50,036
49,637
65,593
Gender in mgmt. (ratio men:women)
59:41
60:40
60:40
Gender in Board of Directors (ratio men:women)
62:38
62:38
67:33
Relevant employees trained in business ethics
99%
99%
99%
Business ethics reviews
Facilitations of the NNWay
Supplier audits
32
34
33
26
32
63
177
236
294
Governance
performance
Product recalls
0
4
3
Failed inspections
0
0
0
Company trust (scale 0-100)
80.6
78.2
84.5
Total tax contribution (DKK million)
26,376
27,527
25,825
Breaches of environmental regulatory limit values
15
16
27
1 Due to COVID-19, the annual employee engagement survey was replaced with more frequent and dynamic surveys tailored to local needs to ensure a continuous check-in with employees through-out
2020. Note: A voluntary assurance report from an independent external auditor for ESG performance is included in the Annual Report 2020.View entire presentation